Taconic Capital Advisors LP's Net Worth
$42.2 Million
Who is Taconic Capital Advisors LP?
Taconic Capital Advisors LP has an estimated net worth of $42.2 Million. This is based on reported shares across multiple companies, which include CORNER GROWTH ACQUISITION CORP. 2, InFinT Acquisition Corp, Prime Impact Acquisition I, Molecular Insight Pharmaceuticals, Inc., and Churchill Capital Corp VI.
SEC CIK
Taconic Capital Advisors LP's CIK is 0001390113
Past Insider Trading and Trends
2023 was Taconic Capital Advisors LP's most active year for disposing of shares, totalling 8 transactions. Taconic Capital Advisors LP's most active month to dispose stocks was the month of July. In 2023 Taconic Capital Advisors LP cashed out on 2,830,000 shares for a total of $30,444,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CORNER GROWTH ACQUISITION CORP. 2 (TRON) Snapshot price: $11.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.14% | -300.00K |
$11.20 | -$3,360,000.00 | 605.16K |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
InFinT Acquisition Corp (IFIN) Snapshot price: $11.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.67% | -305.00K |
$11.01 | -$3,358,000.00 | 445K |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -40.00% | -500.00K |
$10.92 | -$5,460,000.00 | 750K |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Impact Acquisition I No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -700.00K |
$10.82 | -$7,574,000.00 |
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Molecular Insight Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Churchill Capital Corp VI (CCVI) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.95% | -500.00K |
$10.46 | -$5,230,000.00 | 2.63M |
Sep 28
| |||
Form 4
| -14.35% | -525.00K |
$10.40 | -$5,462,500.00 | 3.13M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||